Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
The global pandemic of COVID-19 is a serious public health concern. Over 625 million confirmed cases and more than 6 million deaths have been recorded worldwide. Although several vaccines and antiviral medications have been developed, their efficacy is limited by the emerging new SARS-CoV-2 strains....
Saved in:
Main Authors: | Raahilah, Zahir Essa, Wu, Yuan Seng *, Kalaivani, Batumalaie, Mahendran, Sekar, Poh, Chit Laa * |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/3053/1/Wu%20Yuan%20Seng_Antiviral%20peptides%20against%20SARS-CoV-2.pdf http://eprints.sunway.edu.my/3053/ https://link.springer.com/article/10.1007/s43440-022-00432-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022) -
Development of novel antiviral peptides against dengue serotypes 1-4
by: Lee, Michelle Felicia, et al.
Published: (2023) -
Molecular Mechanisms of Antiviral Agents against Dengue Virus
by: Lee, Michelle Felicia, et al.
Published: (2023) -
Serum Stabilities and Antiviral Activities of Chemically Modified Peptides Against Dengue Serotypes 1–4
by: Lee, Michelle Felicia *, et al.
Published: (2024) -
Inhibition of dengue virus entry into target cells using synthetic antiviral peptides
by: Alhoot, M.A., et al.
Published: (2013)